University Hospital Muenster | Central Study Coordination for Innovative Dermatology (ZiD)

Research site

(Unclaimed)

Location

58 Von-Esmarch Street, Muenster, North Rhine-Westphalia, Germany

Site insights

Top conditions

Top treatments

PF-06651600

Etoposide

Tacrolimus

Ferric Carboxymaltose

Citrate

Liarozole

Durvalumab

Iron

Aflibercept

Lidocaine

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 44 total trials

A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma

The purpose of this study is to learn about the effects of three study medicines (encorafenib, binimetinib, and pembrolizumab) given together for the...

Active, not recruiting

Melanoma

Drug: Binimetinib

Drug: Encorafenib

Locations recently updated

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)

The purpose of this study is to evaluate effect of povorcitinib on itch and skin lesions in participants with prurigo nodularis.

Enrolling

Prurigo Nodularis

Drug: Placebo

Drug: Povorcitinib

Bioavailability and Practicability of Envarsus Versus Advagraf in Liver Transplant Recipients

Trial participants are randomised within 14 days after liver transplantation surgery in a 1:1 ratio to two alternative treatment arms containing eith...

Active, not recruiting

Prophylaxis Against Liver Transplant Rejection

Drug: Tacrolimus capsule

Drug: Tacrolimus Pill

Copanlisib in Combination With Rituximab and CHOP Chemotherapy in Patients With Previously Untreated DLBCL (COPA-R-CHOP)

This is a prospective, multicenter, non-randomized, open-label, phase II study to describe the efficacy of R-CHOP plus copanlisib including a safety...

Active, not recruiting

Diffuse Large B Cell Lymphoma

Drug: R-CHOP Chemotherapy

Drug: Copanlisib

Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients (MODIFY CSX)

The MODIFY CSX study is a randomized, double-blind, controlled trial conducted in heart centers in Germany.In this prospective randomized controlled...

Enrolling

Cardiac Surgery

Valve Surgeries

Drug: Intravenous 0.9% Sodium Chloride

Drug: Long-chain n-3 fatty acids

Long-Term PF-06651600 for the Treatment of Alopecia Areata (ALLEGRO-LT)

This is a global Phase 3 study to evaluate the safety and effectiveness of an investigational study drug (called PF-06651600) in adults and adolescen...

Active, not recruiting

Alopecia Areata

Biological: Meningococcal (groups A, C, W-135 and Y [ACWY]) oligosaccharide diphtheria CRM197 conjugate vaccine

Biological: Tetanus and diphtheria toxoids and acellular pertussis (Tdap) vaccine

Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab (DeLLphi-305)

The primary objective of this study is to compare the efficacy of tarlatamab plus durvalumab with durvalumab alone on prolonging overall survival (OS...

Enrolling

Small-Cell Lung Cancer

Extensive-Stage Small-Cell Lung Cancer

Drug: Tarlatamab

Drug: Durvalumab